
Boston Scientific Corporation BSX
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
1.48 B |
Market Cap[1] |
$ 69.5 B |
EBITDA (LTM) |
$ 5.43 B |
P/E (LTM) |
18.84 |
P/S (LTM) |
3.45 |
EPS (LTM) |
2.57 |
Boston Scientific is an international company that specializes in the development and manufacturing of medical devices and technologies for the treatment of various diseases. It was founded in 1979 in the United States and is now one of the largest medical device manufacturers in the world.
Boston Scientific offers a wide range of medical devices, including stents, cardiac pacemakers, defibrillators, electrodes, urological and gynecological devices, and much more. It also provides physician training, consultation, and patient support services.
The company has offices around the world and serves patients in over 100 countries. Its headquarters are located in Massachusetts, USA.
The goal of Boston Scientific is to help people live healthy lives by providing them with innovative medical devices and technologies. The company actively works on developing new products and improving the quality of its services to meet the needs of its customers.
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
EDAP TMS S.A.
EDAP
|
- | - | $ 162 M | Nasdaq Global Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Inogen
INGN
|
$ 5.45 | 1.11 % | $ 145 M | Nasdaq Global Select Market,SPB | ||
|
Integer Holdings Corporation
ITGR
|
$ 125.5 | 0.15 % | $ 4.36 B | NYSE,SPB | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 22.59 | 1.17 % | $ 530 M | Nasdaq Global Select Market,SPB | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
LivaNova PLC
LIVN
|
$ 81.2 | 2.79 % | $ 4.43 B | Nasdaq Global Select Market | ||
|
Cognyte Software Ltd.
CGNT
|
$ 8.48 | 0.71 % | $ 618 M | Nasdaq Global Select Market,SPB | ||
|
LENSAR
LNSR
|
$ 8.25 | 0.06 % | $ 98.7 M | Nasdaq Capital Market | ||
|
ClearPoint Neuro
CLPT
|
$ 14.05 | 0.67 % | $ 398 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Myomo
MYO
|
$ 1.4 | 1.42 % | $ 58.6 M | NYSE American | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Nano-X Imaging Ltd.
NNOX
|
$ 0.71 | 1.3 % | $ 46 M | Nasdaq Global Select Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
PAVmed
PAVM
|
$ 5.09 | 0.19 % | $ 3.41 M | Nasdaq Capital Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Insulet Corporation
PODD
|
$ 150.58 | 1.65 % | $ 10.6 B | Nasdaq Global Select Market,SPB | ||
|
Quanterix Corporation
QTRX
|
$ 2.58 | 3.98 % | $ 110 M | Nasdaq Global Select Market,SPB | ||
|
AVITA Medical
RCEL
|
$ 10.94 | 1.67 % | $ 305 M | Nasdaq Global Select Market | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.35 | 0.94 % | $ 21.8 M | Nasdaq Capital Market | ||
|
Sintx Technologies
SINT
|
$ 1.54 | 1.32 % | $ 4.27 M | Nasdaq Capital Market | ||
|
SmileDirectClub
SDC
|
- | -53.45 % | $ 9.71 M | Nasdaq Global Select Market | ||
|
Sientra
SIEN
|
- | -16.59 % | $ 10.3 M | Nasdaq Global Select Market | ||
|
Silk Road Medical, Inc
SILK
|
- | - | $ 1.07 B | Nasdaq Global Select Market,SPB | ||
|
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market | ||
|
Surgalign Holdings
SRGA
|
- | -32.98 % | $ 1.68 M | Nasdaq Global Select Market | ||
|
ShockWave Medical
SWAV
|
- | - | $ 12.3 B | Nasdaq Global Select Market,SPB | ||
|
NuVasive
NUVA
|
- | - | $ 2.07 B | Nasdaq Global Select Market,SPB | ||
|
Natus Medical Incorporated
NTUS
|
- | 1.94 % | $ 1.05 B | Nasdaq Global Select Market,SPB | ||
|
Nevro Corp.
NVRO
|
- | - | $ 217 M | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.